Tag: Magnus Essand

Oncolytic virus clinical trial Uppsala

Oncolytic Virus Clinical Trial for Neuroendocrine Tumor Patients Begins at Uppsala University, Sweden

April 6, 2016

It is with great excitement that we share the announcement of the start of the AdVince clinical trial  for neuroendocrine cancer patients at Uppsala University in Sweden – the oncolytic virus is on its way to the first patient in the trial!!

 

What…

READ MORE
alexander masters

A Possible Cure for Neuroendocrine Cancer: Exciting Update!

June 19, 2013

Back in September 2012 we shared the following:  “For $1.6 million (1 million pounds) an oncolytic virus that has the potential to cure neuroendocrine cancer can be named for the donor.  At Uppsala University in Sweden researchers are ready to start a …

READ MORE
zebra cartoon episode 1

10 Highlights of the Year 2012 for the Carcinoid and Neuroendocrine Tumor Community

December 20, 2012

As the Carcinoid Cancer Foundation looks back on the year 2012, there were many significant events and advances for the carcinoid and neuroendocrine tumor (NET) community.  Here are 10 of the year’s important stories:

1)       NET Cancer Day, November

READ MORE
magnus essand

A Possible Cure for Neuroendocrine Cancer — It Can Be Named for You or a Loved One

September 1, 2012

For $1.6 million (1 million pounds) an oncolytic virus that has the potential to cure neuroendocrine cancer can be named for the donor.  At Uppsala University in Sweden researchers are ready to start a clinical trial for up to 20 NET (neuroendocrine tumor)…

READ MORE